Medizinische Universitätsklinik Bochum

www.medunikkh.de

HerFLOT (AIO-STO-0310) Multicenter, explorative phase II study of perioperative 5-FU, leucovorin, docetaxel, and oxaliplatin (FLOT) in combination with trastuzumab in patients with HER2-positive, locally advanced, resectable adenocarcinoma of the gastroesophageal junction or stomach

HerFLOT (AIO-STO-0310)

Studienleitung: Prof. Hofheinz
AIO Studie

Ansprechpartner